image
Editas Medicine, Inc. EDIT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.66
-3.97 %
$ 220 M
Market Cap
-1.05
P/E
INCOME STATEMENT
78.1 M REVENUE
296.32%
Growth Rates
1Year 296.32%
3Years -4.87%
5Years 19.59%
7Years 44.11%
10Years 0.00%
-169 M OPERATING INCOME
25.12%
Growth Rates
1Year 25.12%
3Years -7.86%
5Years -8.27%
7Years -8.24%
10Years -41.60%
-153 M NET INCOME
30.49%
Growth Rates
1Year 30.49%
3Years -9.73%
5Years -6.86%
7Years -6.72%
10Years -40.06%
EFFICIENCY
Earnings Waterfall Editas Medicine, Inc.
image
Revenue 78.1 M
Cost Of Revenue 178 M
Gross Profit -99.5 M
Operating Expenses 247 M
Operating Income -169 M
Other Expenses -16 M
Net Income -153 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 78.1 19.7 25.5 90.7 20.5 31.9 13.7 6.1 1.6 0 0
GROSS PROFIT
Cost Of Revenue 177.7 6.3 5.1 158.0 96.9 90.7 83.2 57.0 18.8 5.1 1.6
Gross Profit (99.5) 13.4 20.5 (67.3) (76.4) (58.7) (69.4) (50.9) (17.2) (5.1) (1.6)
OPERATING INCOME
Operating Expenses 247.3 245.7 218.7 225.6 161.5 145.7 133.7 103.2 36.9 12.7 3.7
Selling, General and Administrative Expenses 69.7 70.7 76.2 67.6 64.6 55.0 50.5 46.3 18.1 7.7 3.6
Research and Development Expenses 177.7 175.0 142.5 158.0 96.9 90.7 83.2 57.0 18.8 5.1 1.6
Operating Income (169.2) (225.9) (193.1) (134.8) (140.9) (113.7) (119.9) (97.2) (35.3) (12.7) (5.2)
PRE-TAX INCOME
Interest Income Expense 0 4.2 0 0 0 0 1.0 0 0.1 34 K 0
Total Other Income 16.0 5.5 0.6 18.9 7.2 3.8 (0.4) 5 K (37.6) (1.0) 54 K
Pre-Tax Income (153.2) (220.4) (192.5) (116.0) (133.7) (110.0) (120.3) (97.2) (72.9) (13.7) (5.3)
NET INCOME
Tax Provision 0 (16.1) (7.4) (6.6) (10.3) (3.1) (1.1) (1.3) (37.8) (0.9) 75 K
Net Income (153.2) (204.4) (185.1) (109.4) (123.5) (110.0) (120.3) (97.2) (72.9) (13.7) (5.3)
EPS 2.02 2.98 2.74 1.87 2.47 2.33 2.98 3.02 2.04 0.89 17.8